Alternative Investments Propanc Biopharma Secures Up to $100M in Strategic Funding from Hexstone Capital15 October 20250 Views Propanc Biopharma, a biotech company developing therapies aimed at preventing cancer relapse, has announced a strategic financing agreement with investment…
